Trueblue Financials
Trueblue (TBI) reported $1.6B in revenue for fiscal year 2025, up 3.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Debt-funded liquidity is now supporting a receivable-heavy business whose margin cushion no longer converts reliably into cash.
Even with a smaller accounting loss, cash conversion deteriorated: operating cash flow was-$58.0M while financing cash flow was$57.1M , showing the year was funded mostly by borrowing rather than by operations. The simultaneous rise in receivables means the slight sales recovery pulled cash into customer balances instead of back into the bank.
This looks like a business where gross margin used to buffer demand swings, but that cushion weakened in the latest year as margin fell to
The balance sheet is still more liquidity-supported than leverage-driven, with liabilities below equity and a current ratio of 2.1x. But the composition matters: cash was only
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Trueblue's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Trueblue has an operating margin of -2.9%, meaning the company loses $3 on every $100 of revenue. This results in a profitability score of 24/100. This is up from -5.9% the prior year.
Trueblue's revenue grew a modest 3.1% year-over-year to $1.6B. This slow but positive growth earns a score of 13/100.
Trueblue carries a low D/E ratio of 0.24, meaning only $0.24 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 72/100, indicating a strong balance sheet with room for future borrowing.
Trueblue's current ratio of 2.15 indicates adequate short-term liquidity, earning a score of 61/100. The company can meet its near-term obligations, though with limited headroom.
Trueblue's operations used $58.0M of cash, and capex of $15.7M added to the outflow, for a free cash flow shortfall of $73.7M. This results in a cash flow score of 23/100.
Trueblue posts a -17.5% return on equity (ROE), meaning it loses $17 for every $100 of shareholders' equity. This results in a returns score of 17/100. This is up from -39.9% the prior year.
Trueblue scores 3.77, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Trueblue passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Trueblue reported a net loss of $48.0M while operations used $58.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Trueblue generated $1.6B in revenue in fiscal year 2025. This represents an increase of 3.1% from the prior year.
Trueblue's EBITDA was -$17.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 71.9% from the prior year.
Trueblue reported -$48.0M in net income in fiscal year 2025. This represents an increase of 61.9% from the prior year.
Trueblue earned -$1.61 per diluted share (EPS) in fiscal year 2025. This represents an increase of 61.4% from the prior year.
Cash & Balance Sheet
Trueblue recorded an outflow of $73.7M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 78.9% from the prior year.
Trueblue held $24.5M in cash against $65.8M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Trueblue's gross margin was 22.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 3.2 percentage points from the prior year.
Trueblue's operating margin was -2.9% in fiscal year 2025, reflecting core business profitability. This is up 3.0 percentage points from the prior year.
Trueblue's net profit margin was -3.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.0 percentage points from the prior year.
Trueblue's ROE was -17.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 22.4 percentage points from the prior year.
Capital Allocation
Trueblue repurchased no shares in fiscal year 2025. This represents a decrease of 100.0% from the prior year.
Trueblue invested $15.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 35.1% from the prior year.
Not reported for fiscal year 2025.
TBI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.6B+3.1% | $1.6B-17.8% | $1.9B-15.4% | $2.3B+3.7% | $2.2B+17.7% | $1.8B-22.1% | $2.4B-5.2% | $2.5B-0.4% | $2.5B-8.8% | $2.8B+677.0% | $354.0M-83.7% | $2.2B+30.3% | $1.7B+20.1% | $1.4B+5.6% | $1.3B |
| Cost of Revenue | $1.3B | $1.2B+7.5% | $1.2B-17.1% | $1.4B-15.2% | $1.7B+2.4% | $1.6B+14.8% | $1.4B-19.6% | $1.7B-5.1% | $1.8B-1.6% | $1.9B-9.5% | $2.1B | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $358.5M | $367.8M-9.5% | $406.4M-19.7% | $506.1M-16.0% | $602.1M+7.5% | $560.3M+27.2% | $440.6M-28.9% | $619.9M-5.4% | $655.4M+3.3% | $634.5M-6.7% | $679.7M | N/A | $537.0M+21.4% | $442.3M+18.8% | $372.4M+7.3% | $347.0M |
| SG&A Expenses | $357.8M | $371.1M-9.7% | $410.9M-16.9% | $494.6M-1.2% | $500.7M+7.8% | $464.3M+13.7% | $408.3M-20.9% | $516.2M-4.5% | $540.5M+5.8% | $510.8M-6.5% | $546.5M+10.2% | $496.0M+16.5% | $425.8M+17.5% | $362.2M+20.6% | $300.5M+6.2% | $282.8M |
| Operating Income | -$48.6M | -$46.6M+49.7% | -$92.8M-289.0% | -$23.9M-133.0% | $72.2M+5.5% | $68.4M+139.1% | -$174.9M-364.3% | $66.2M-10.5% | $73.9M-4.7% | $77.6M+556.4% | -$17.0M-117.4% | $97.8M+19.7% | $81.7M+37.2% | $59.6M+12.3% | $53.0M+10.9% | $47.8M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $2.8M-43.0% | $4.9M-11.2% | $5.5M-23.3% | $7.2M+72.3% | $4.2M+31.8% | $3.2M+152.9% | $1.2M+10.3% | $1.1M-6.3% | $1.2M |
| Income Tax | $3.3M | $2.3M-93.7% | $37.2M+675.2% | -$6.5M-158.1% | $11.1M-8.8% | $12.2M+138.9% | -$31.4M-550.7% | $7.0M-29.6% | $9.9M-55.2% | $22.1M+534.2% | -$5.1M-120.2% | $25.2M+55.9% | $16.2M+1.0% | $16.0M-23.7% | $21.0M+13.2% | $18.5M |
| Net Income | -$56.6M | -$48.0M+61.9% | -$125.7M-787.2% | -$14.2M-122.8% | $62.3M+1.0% | $61.6M+143.5% | -$141.8M-324.9% | $63.1M-4.1% | $65.8M+18.6% | $55.5M+463.6% | -$15.3M-121.4% | $71.2M+8.5% | $65.7M+46.2% | $44.9M+33.6% | $33.6M+9.2% | $30.8M |
| EPS (Diluted) | — | -$1.61+61.4% | -$4.17-826.7% | -$0.45-124.2% | $1.86+6.9% | $1.74+143.4% | -$4.01-349.1% | $1.61-1.2% | $1.63+21.6% | $1.34+462.2% | -$0.37-121.6% | $1.71+7.5% | $1.59+43.2% | $1.11+32.1% | $0.84+15.1% | $0.73 |
Not reported in any period shown, so not listed: R&D Expenses.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
TBI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $638.7M-5.4% | $675.4M-24.9% | $899.4M-11.8% | $1.0B-1.3% | $1.0B+5.4% | $980.6M-13.7% | $1.1B+1.9% | $1.1B+0.5% | $1.1B-1.9% | $1.1B-10.2% | $1.3B+18.1% | $1.1B+48.3% | $719.5M+19.6% | $601.7M+7.3% | $560.8M |
| Current Assets | $297.6M+7.4% | $277.1M-21.9% | $355.0M-17.5% | $430.2M-3.3% | $445.1M+17.5% | $378.9M-10.2% | $421.7M-1.9% | $429.8M+0.4% | $428.3M+0.1% | $427.8M-21.2% | $543.0M+30.6% | $415.8M+16.6% | $356.5M+12.4% | $317.2M+13.0% | $280.6M |
| Cash & Equivalents | $24.5M+8.8% | $22.5M-63.6% | $61.9M-14.1% | $72.1M+44.4% | $49.9M-20.2% | $62.5M+66.2% | $37.6M-20.0% | $47.0M+63.3% | $28.8M-17.7% | $35.0M+17.4% | $29.8M+51.4% | $19.7M-83.9% | $122.0M-5.8% | $129.5M+18.5% | $109.3M |
| Accounts Receivable | $241.2M+12.4% | $214.7M-15.0% | $252.5M-19.6% | $314.3M-11.2% | $353.9M+27.1% | $278.3M-18.7% | $342.3M-3.7% | $355.4M-5.0% | $374.3M+6.1% | $352.6M-23.6% | $461.5M+28.2% | $359.9M+80.4% | $199.5M+19.3% | $167.3M+8.7% | $153.9M |
| Goodwill | $42.5M+73.1% | $24.5M-70.8% | $84.1M-10.3% | $93.8M-0.8% | $94.5M-0.4% | $94.9M-60.1% | $237.5M+0.1% | $237.3M+4.7% | $226.7M+1.1% | $224.2M-16.5% | $268.5M+11.0% | $241.9M+194.1% | $82.2M+71.0% | $48.1M-0.1% | $48.1M |
| Total Liabilities | $364.1M+1.1% | $360.0M-18.5% | $441.5M-15.6% | $523.1M-3.2% | $540.2M-0.6% | $543.4M+6.5% | $510.2M-2.5% | $523.4M-5.6% | $554.2M-8.4% | $605.3M-16.4% | $723.9M+21.2% | $597.3M+83.2% | $326.1M+21.6% | $268.1M+0.3% | $267.2M |
| Current Liabilities | $138.5M-13.5% | $160.1M-21.5% | $204.1M-16.0% | $242.9M-6.1% | $258.5M-3.9% | $269.0M+16.5% | $230.8M+2.3% | $225.5M+6.2% | $212.4M-15.4% | $251.1M+10.2% | $228.0M+21.8% | $187.2M+54.2% | $121.4M+6.9% | $113.6M+1.1% | $112.3M |
| Long-Term Debt | $65.8M+765.8% | $7.6M | $0 | N/A | $0 | $0-100.0% | $37.1M-53.6% | $80.0M-31.3% | $116.5M-13.9% | $135.4M-44.4% | $243.4M+22.1% | $199.4M+572.3% | $29.7M | N/A | N/A |
| Total Equity | $274.6M-12.9% | $315.4M-31.1% | $457.9M-7.7% | $496.3M+0.7% | $493.1M+12.8% | $437.2M-30.2% | $626.0M+5.8% | $591.4M+6.6% | $554.8M+5.6% | $525.2M-1.9% | $535.6M+14.1% | $469.3M+19.3% | $393.4M+17.9% | $333.7M+13.7% | $293.6M |
| Retained Earnings | $296.2M-12.2% | $337.6M-29.5% | $478.6M-7.3% | $516.3M+1.5% | $508.8M+12.6% | $452.0M-29.3% | $639.2M+5.5% | $606.1M+7.9% | $561.6M+4.7% | $536.6M-2.4% | $549.6M+17.3% | $468.5M+19.7% | $391.3M+18.3% | $330.9M+13.7% | $290.9M |
Not reported in any period shown, so not listed: Inventory.
TBI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$54.5M | -$58.0M-240.3% | -$17.1M-149.1% | $34.8M-71.2% | $120.5M+489.5% | $20.4M-86.6% | $152.5M+63.1% | $93.5M-25.6% | $125.7M+25.5% | $100.1M-61.6% | $260.7M+261.7% | $72.1M+51.7% | $47.5M-44.8% | $86.1M+64.5% | $52.3M+71.1% | $30.6M |
| Capital Expenditures | $12.9M | $15.7M-35.1% | $24.2M-22.8% | $31.3M+2.1% | $30.6M-12.5% | $35.0M+29.3% | $27.1M-3.7% | $28.1M+64.9% | $17.1M-22.3% | $22.0M-24.4% | $29.0M+57.9% | $18.4M+8.7% | $16.9M+30.1% | $13.0M-27.1% | $17.8M+83.6% | $9.7M |
| Free Cash Flow | -$67.4M | -$73.7M-78.9% | -$41.2M-1284.8% | $3.5M-96.1% | $89.9M+717.0% | -$14.6M-111.6% | $125.5M+91.8% | $65.4M-39.8% | $108.6M+39.0% | $78.2M-66.3% | $231.7M+331.6% | $53.7M+75.4% | $30.6M-58.1% | $73.1M+111.8% | $34.5M+65.2% | $20.9M |
| Investing Cash Flow | $13.8M | -$16.1M-554.8% | -$2.5M+92.4% | -$32.3M-54.3% | -$20.9M-29.1% | -$16.2M+52.9% | -$34.4M-59.1% | -$21.6M-5.4% | -$20.5M+62.3% | -$54.4M+56.1% | -$123.9M-18.0% | -$105.0M+67.0% | -$318.4M-154.2% | -$125.3M-379.0% | -$26.2M+2.9% | -$26.9M |
| Financing Cash Flow | $27.7M | $57.1M+434.4% | -$17.1M+54.5% | -$37.6M+41.9% | -$64.7M-238.2% | -$19.1M+79.3% | -$92.5M-11.6% | -$82.9M-10.5% | -$75.0M+0.4% | -$75.3M+34.6% | -$115.1M-369.1% | $42.8M-74.8% | $169.8M+424.5% | $32.4M+624.3% | -$6.2M+89.2% | -$57.2M |
| Share Buybacks | N/A | $0-100.0% | $21.3M-37.7% | $34.2M-43.9% | $60.9M+265.4% | $16.7M-68.1% | $52.3M+34.8% | $38.8M+11.5% | $34.8M-5.1% | $36.7M+538.1% | $5.7M | $0 | $0 | $0-100.0% | $4.4M-92.3% | $56.9M |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
TBI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 22.8%-3.2pp | 25.9%-0.6pp | 26.6%-0.2pp | 26.7%+0.9pp | 25.8%+1.9pp | 23.9%-2.3pp | 26.2%-0.1pp | 26.2%+0.9pp | 25.3%+0.6pp | 24.7% | N/A | 24.7%-1.8pp | 26.5%-0.3pp | 26.8%+0.4pp | 26.4% |
| Operating Margin | -2.9%+3.0pp | -5.9%-4.7pp | -1.3%-4.5pp | 3.2%+0.1pp | 3.1%+12.6pp | -9.5%-12.3pp | 2.8%-0.2pp | 3.0%-0.1pp | 3.1%+3.7pp | -0.6%-28.3pp | 27.6%+23.9pp | 3.8%+0.2pp | 3.6%-0.2pp | 3.8%+0.2pp | 3.6% |
| Net Margin | -3.0%+5.0pp | -8.0%-7.3pp | -0.7%-3.5pp | 2.8%-0.1pp | 2.8%+10.5pp | -7.7%-10.3pp | 2.7%0.0pp | 2.6%+0.4pp | 2.2%+2.8pp | -0.5%-20.7pp | 20.1%+17.1pp | 3.0%+0.3pp | 2.7%+0.3pp | 2.4%+0.1pp | 2.3% |
| Return on Equity | -17.5%+22.4pp | -39.9%-36.8pp | -3.1%-15.7pp | 12.6%+0.1pp | 12.5%+44.9pp | -32.4%-42.5pp | 10.1%-1.0pp | 11.1%+1.1pp | 10.0%+12.9pp | -2.9%-16.2pp | 13.3%-0.7pp | 14.0%+2.6pp | 11.4%+1.3pp | 10.1%-0.4pp | 10.5% |
| Return on Assets | -7.5%+11.1pp | -18.6%-17.0pp | -1.6%-7.7pp | 6.1%+0.1pp | 6.0%+20.4pp | -14.5%-20.0pp | 5.5%-0.3pp | 5.9%+0.9pp | 5.0%+6.3pp | -1.4%-7.0pp | 5.7%-0.5pp | 6.2%-0.1pp | 6.2%+0.6pp | 5.6%+0.1pp | 5.5% |
| Current Ratio | 2.15+0.4x | 1.730.0x | 1.740.0x | 1.770.0x | 1.72+0.3x | 1.41-0.4x | 1.83-0.1x | 1.91-0.1x | 2.02+0.3x | 1.70-0.7x | 2.38+0.2x | 2.22-0.7x | 2.94+0.1x | 2.79+0.3x | 2.50 |
| Debt-to-Equity | 0.24+0.2x | 0.020.0x | 0.00-1.1x | 1.05+1.1x | 0.000.0x | 0.00-0.1x | 0.06-0.1x | 0.14-0.1x | 0.210.0x | 0.26-0.2x | 0.450.0x | 0.42+0.3x | 0.08-0.7x | 0.80-0.1x | 0.91 |
| FCF Margin | -4.6%-1.9pp | -2.6%-2.8pp | 0.2%-3.8pp | 4.0%+4.7pp | -0.7%-7.5pp | 6.8%+4.0pp | 2.8%-1.6pp | 4.3%+1.2pp | 3.1%-5.3pp | 8.4%-6.7pp | 15.2%+13.8pp | 1.4%-3.0pp | 4.4%+1.9pp | 2.5%+0.9pp | 1.6% |
Similar Companies
Where Trueblue Ranks
Frequently Asked Questions
What is Trueblue's annual revenue?
Trueblue (TBI) reported $1.6B in total revenue for fiscal year 2025. This represents a 3.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Trueblue's revenue growing?
Trueblue (TBI) revenue grew by 3.1% year-over-year, from $1.6B to $1.6B in fiscal year 2025.
Is Trueblue profitable?
No, Trueblue (TBI) reported a net income of -$48.0M in fiscal year 2025, with a net profit margin of -3.0%.
What is Trueblue's EBITDA?
Trueblue (TBI) had EBITDA of -$17.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Trueblue have?
As of fiscal year 2025, Trueblue (TBI) had $24.5M in cash and equivalents against $65.8M in long-term debt.
What is Trueblue's gross margin?
Trueblue (TBI) had a gross margin of 22.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Trueblue's operating margin?
Trueblue (TBI) had an operating margin of -2.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Trueblue's net profit margin?
Trueblue (TBI) had a net profit margin of -3.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Trueblue's return on equity (ROE)?
Trueblue (TBI) has a return on equity of -17.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Trueblue's free cash flow?
Trueblue (TBI) recorded an outflow of $73.7M in free cash flow during fiscal year 2025. This represents a -78.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Trueblue's operating cash flow?
Trueblue (TBI) recorded an outflow of $58.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Trueblue's total assets?
Trueblue (TBI) had $638.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Trueblue's capital expenditures?
Trueblue (TBI) invested $15.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Trueblue's current ratio?
Trueblue (TBI) had a current ratio of 2.15 as of fiscal year 2025, which is generally considered healthy.
What is Trueblue's debt-to-equity ratio?
Trueblue (TBI) had a debt-to-equity ratio of 0.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Trueblue's return on assets (ROA)?
Trueblue (TBI) had a return on assets of -7.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Trueblue's cash runway?
Based on fiscal year 2025 data, Trueblue (TBI) had $24.5M in cash against an annual operating cash burn of $58.0M. This gives an estimated cash runway of approximately 5 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Trueblue's Altman Z-Score?
Trueblue (TBI) has an Altman Z-Score of 3.77, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Trueblue's Piotroski F-Score?
Trueblue (TBI) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Trueblue's earnings high quality?
Trueblue (TBI) reported a net loss of $48.0M while operations used $58.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Trueblue?
Trueblue (TBI) scores 35 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.